Last Updated on October 11, 2024 by The Health Master
Accord Healthcare, Inc. is voluntarily recalling a single lot of Daptomycin for Injection 500 mg/vial, and Daptomycin for Injection 350 mg/vial product contained in cartons imprinted with lot # R2200232 Exp: 01/2025 to the consumer/user level.
This product is being recalled because Accord received a product complaint report from a hospital pharmacy that vials labeled as “Daptomycin for Injection 500 mg/vial” were found in cartons labeled as “Daptomycin for Injection 350 mg/vial”.
The lot and expiration date printed on the outer carton and inner vial are the same and correspond to “Daptomycin for Injection 500 mg/vial.”
Accordingly, Accord is voluntarily recalling all of lot #R2200232, Daptomycin for Injection 500 mg/vial, which may be in outer cartons that read “Daptomycin for Injection 500 mg/vial” OR “Daptomycin for Injection 350 mg/vial.”
| Product | NDC | Lot number/Expiration Date |
|---|---|---|
| Daptomycin for Injection 500 mg/vial | 16729-435-05 | R2200232, 01/2025 |
| Daptomycin for Injection 350 mg/vial | 16729-434-05 |
Risk Statement: Administration of Daptomycin 500 mg/vial, to the population most at risk which are children or patients with renal impairment, there is a reasonable probability that the likelihood of the labeled warnings can potentially be increased if a higher than the intended dose is used which could lead to serious adverse health consequences.
If these reactions occur, they may require medical treatment such as hemodialysis and systemic glucocorticoids. To date, Accord has not received any reports of adverse events related to this recall.
The product is used for the treatment of adult and pediatric patients (1 to 17 years of age) with complicated skin and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive bacteria:
- Staphylococcus aureaus (including methicillin-resistant isolates),
- Streptococcus pyogenes,
- Streptococcus agalactiae,
- Streptococcus dysgalactiae subsp. equisimilis,
- Enterococcus faecalis (vancomycin-susceptible isolates only).
The lot number, NDC number and expiration date of affected Daptomycin 500 mg/vial and Daptomycin 350 mg/vial product is shown in the table below:
| Product | NDC | Lot number/Expiration Date |
|---|---|---|
| Daptomycin for Injection 500 mg/vial | 16729-435-05 | R2200232, 01/2025 |
| Daptomycin for Injection 350 mg/vial | 16729-434-05 |
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration (USFDA).
Drug recall: Vancomycin Hydrochloride Injection recalled due to this reason
Drug recall: 4 lots of Quinapril Tablets recalled due to this reason
Drug recall: This Blood Pressure tablets recalled
Drug recall: Sodium Bicarbonate Injection recalled due to this reason
Drug recall: Dr Reddy’s, Sun Pharma recall these drugs due to this reason
Drug recall: FDA issues nationwide recall for Ferric Carboxymaltose
New BCG vaccine for TB: Clinical trials to start soon
Drug licences of these two firms suspended: FDA Manipur
Fake pharma firm busted, two arrested
USFDA approves Fesoterodine Fumarate Extended-Release tablets
Medical Device alert: CDSCO issues medical device alert on MitraClip Clip Delivery System
Drug recall: Vancomycin Hydrochloride Injection recalled due to this reason
List of approved New Drugs Updated
No need to recall, re-label the drug for price revision if…….:NPPA
Registration for sale of Medical Devices: Procedure and conditions
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
